Provider record
Is MEDVi legit?
Yes — MEDVi is a real, operating US telehealth company, not a fake storefront. That is usually what the question means, and it is the easy part.
The harder part is what it sells you. It supplies compounded medication — prepared by a compounding pharmacy, not an FDA-approved product. We have 1 sourced regulatory or legal action on record against it, listed below with links to the primary documents.
What it actually supplies
Supplies compounded semaglutide or tirzepatide — medication prepared by a compounding pharmacy, not an FDA-approved product. Cheaper, legal, and the category the FDA has been issuing warning letters about.
Named on its own site: compounded semaglutide, compounded tirzepatide.
What regulators and courts have said
Each of these links to the primary document. We publish what the record says and nothing beyond it — an action against a company is not proof that a particular customer was harmed.
2026-02
FDA warning letter to MEDVi, LLC dba MEDVi (MARCS-CMS 721455) alleging the products carried MEDVi branding that falsely suggested MEDVi was the compounder, that claims such as 'same active ingredient as Wegovy and Ozempic' implied FDA approval, and that the products were misbranded under FD&C Act sections 502(a) and 502(bb), with seizure, injunction and border detention warned as possible consequences.
Worth knowing
Compounded semaglutide is $179 first month then $299/month for refills; compounded tirzepatide $299/month flat, consultation and shipping bundled. Pricing comes from a third-party index verified 10 August 2026 because medvi.com blocks automated retrieval, so a human must confirm before publication.
Go direct
Cheaper on paper
Providers with a lower advertised starting price. Check what each one supplies before comparing.
If you would rather stay with FDA-approved medication
These supply approved drugs only and carry nothing on their record here.
Straight answers
- Is MEDVi legit?
- MEDVi is a real, operating US telehealth company, not a fake storefront. It supplies compounded semaglutide or tirzepatide, which is medication prepared by a compounding pharmacy rather than an FDA-approved product. We have 1 sourced regulatory or legal action on record against it: FDA warning letter to MEDVi, LLC dba MEDVi (MARCS-CMS 721455) alleging the products carried MEDVi branding that falsely suggested MEDVi was the compounder, that claims such as 'same active ingredient as Wegovy and Ozempic' implied FDA approval, and that the products were misbranded under FD&C Act sections 502(a) and 502(bb), with seizure, injunction and border detention warned as possible consequences.
- Does MEDVi sell compounded or FDA-approved medication?
- Compounded only. Supplies compounded semaglutide or tirzepatide — medication prepared by a compounding pharmacy, not an FDA-approved product. Cheaper, legal, and the category the FDA has been issuing warning letters about.
- How much does MEDVi cost?
- From $299 a month, medication included. A promotional first month is advertised at $179.